<産業資料/調査レポートの題名> 2022年7月15日

自己免疫疾患の世界市場:疾患別(限局性、全身性)、診断別(IFA、ELISA、ドットブロット、ラインブロット、凝集反応、二重免疫拡散法、ウエスタンブロッティング、多重イムノアッセイ、その他)、製品別(医薬品、治療・モニター機器、診断機器)、地域別予測


◆英文タイトル:Global Autoimmune Disease Market Size study, by Disease Type (Localized, Systemic), by Diagnostic (IFA, ELISA, Dot blot, Line Blot, Agglutination, Double Immune Diffusion, Western Blotting, Multiplex Immunoassay, Others), by Product (Drugs, Therapeutic & Monitoring Equipment, Diagnostic Equipment) and Regional Forecasts 2018-2025

TABLE OF CONTENTS

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1. Autoimmune Disease Market, by Disease Type, 2015-2025 (USD Billion)
1.3.2. Autoimmune Disease Market, by Diagnostics, 2015-2025 (USD Billion)
1.3.3. Autoimmune Disease Market, by Products, 2015-2025 (USD Billion)
1.3.4. Autoimmune Disease Market, by Region, 2015-2025 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Autoimmune Disease Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Autoimmune Disease Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Autoimmune Disease Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Value Chain Analysis
4.3.1. Supplier
4.3.2. Manufacturers/Service Provider
4.3.3. Distributors
4.3.4. End-Users
4.4. Key Buying Criteria
4.5. Regulatory Framework
4.6. Cost Structure Analysis
4.6.1. Raw Material Cost Analysis
4.6.2. Manufacturing Cost Analysis
4.6.3. Labour Cost Analysis
4.7. Investment Vs Adoption Scenario
4.8. Analyst Recommendation & Conclusion
Chapter 5. Autoimmune Disease Market, by Disease Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Key Market Players
5.4. Autoimmune Disease Market, Sub Segment Analysis
5.4.1. Localized
5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2. Systemic
5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Autoimmune Disease Market, by Diagnostics
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Key Market Players
6.4. Autoimmune Disease Market, Sub Segment Analysis
6.4.1. IFA
6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2. ELISA
6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3. Dot blot
6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4. Line blot
6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5. Agglutination
6.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6. Double Immune Diffusion
6.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.7. Western Blotting
6.4.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.8. Multiplex Immunoassay
6.4.8.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.8.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.9. Others
6.4.9.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.9.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Autoimmune Disease Market, by Product
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Key Market Players
7.4. Autoimmune Disease Market, Sub Segment Analysis
7.4.1. Drugs
7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2. Therapeutic & Monitoring Equipment
7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3. Diagnostic Equipment
7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Autoimmune Disease Market, by Regional Analysis
8.1. Autoimmune Disease Market, Regional Market Snapshot (2015-2025)
8.2. North America Autoimmune Disease Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Autoimmune Disease Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. France
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4. Rest of Europe
8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Autoimmune Disease Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Autoimmune Disease Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.2. Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.2.4. End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Active Biotech
9.3.3. Eli Lilly
9.3.4. Bristol-Myers Squibb
9.3.5. AstraZeneca plc
9.3.6. Pfizer
9.3.7. Biogen Idec
9.3.8. Lupin Limited
9.3.9. GlaxoSmithKline
9.3.10. Amgen
9.3.11. 4SC
9.3.12. F. Hoffmann-La Roche Ltd.
9.3.13. AutoImmune Inc.
9.3.14. Johnson & Johnson
9.3.15. Bayer
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark